Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
Abigail Colson, Alec Morton, Christine Årdal, et al.
Value in Health (2021) Vol. 24, Iss. 12, pp. 1828-1834
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The past, present, and future of antibiotics
Michael A. Cook, Gerard D. Wright
Science Translational Medicine (2022) Vol. 14, Iss. 657
Closed Access | Times Cited: 356
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
Ghazala Muteeb, Md Tabish Rehman, Moyad Shahwan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1615-1615
Open Access | Times Cited: 264
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
Ankita Parmanik, Soumyajit Das, Biswakanth Kar, et al.
Current Microbiology (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 137
Unveiling biological activities of biosynthesized starch/silver-selenium nanocomposite using Cladosporium cladosporioides CBS 174.62
Fathy M. Elkady, Amr H. Hashem, Salem S. Salem, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Watermelon Rind Mediated Biosynthesis of Bimetallic Selenium-Silver Nanoparticles: Characterization, Antimicrobial and Anticancer Activities
Amr H. Hashem, Gharieb S. El‐Sayyad, Abdulaziz A. Al–Askar, et al.
Plants (2023) Vol. 12, Iss. 18, pp. 3288-3288
Open Access | Times Cited: 16
Green biosynthesis of bimetallic selenium–gold nanoparticles using Pluchea indica leaves and their biological applications
Ahmed Mohamed Aly Khalil, Ebrahim Saied, Alsayed E. Mekky, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 11
Open Access | Times Cited: 7
Microbial lipopeptides: their pharmaceutical and biotechnological potential, applications, and way forward
K. P. Sreelakshmi, M. Madhuri, R. Swetha, et al.
World Journal of Microbiology and Biotechnology (2024) Vol. 40, Iss. 4
Closed Access | Times Cited: 5
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
Laurence S. J. Roope, Liz Morrell, James Buchanan, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 4
Antibacterial potential of silver–selenium nanocomposites in mitigating fire blight disease in Pyrus communis L
Muhammad Imran, Muhammad Umer, Naveed Iqbal Raja, et al.
Frontiers in Plant Science (2025) Vol. 16
Open Access
The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study
Cecilia Kållberg, Liv Mathiesen, Unni Gopinathan, et al.
Journal of Pharmaceutical Policy and Practice (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Isolation, Identification, and Antibacterial Properties of Prodigiosin, a Bioactive Product Produced by a New Serratia marcescens JSSCPM1 Strain: Exploring the Biosynthetic Gene Clusters of Serratia Species for Biological Applications
Rajaguru Arivuselvam, Ayed A. Dera, Syed Parween Ali, et al.
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1466-1466
Open Access | Times Cited: 10
Examining how well economic evaluations capture the value of mental health
James Lathe, Richard J. Silverwood, Alun D. Hughes, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 3, pp. 221-230
Open Access | Times Cited: 3
The economic challenges of new drug development
Laurence S. J. Roope
Journal of Controlled Release (2022) Vol. 345, pp. 275-277
Open Access | Times Cited: 11
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
Luke Moore, María Virginia Villegas, Eric Wenzler, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 6, pp. 1445-1463
Open Access | Times Cited: 6
Antimicrobial drug pricing
Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom
Jason Gordon, Maria Gheorghe, Simon Goldenberg, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 12, pp. 1657-1673
Open Access | Times Cited: 3
Succinct review on emergent crisis of antibiotics resistant (MDR) bacteria: impact on human health worldwide
Kirti Rani
Journal of Bacteriology & Mycology Open Access (2024) Vol. 12, Iss. 3, pp. 94-96
Closed Access
Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model
Wenqianzi Yang, Xuemei Zhen, Xueshan Sun, et al.
BMJ Open (2024) Vol. 14, Iss. 8, pp. e086039-e086039
Open Access
Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model
Marieke Schurer, Renu Patel, Marjolijn van Keep, et al.
Frontiers in Medical Technology (2023) Vol. 5
Open Access | Times Cited: 1
Netflix and pill: is there a role for volume-delinked subscription-style payments beyond antimicrobials?’
Grace Hampson, Lotte Steuten
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 24, Iss. 1, pp. 1-3
Open Access | Times Cited: 1
Novel medicinal and synthetic chemistry strategies against antimicrobial resistance
Elham Rezaee, Maryam Nazari, Mona Mosayebnia, et al.
Elsevier eBooks (2022), pp. 1-34
Closed Access | Times Cited: 1
Problems of assessing economic effectiveness of antimicrobial agents: an experience of the Russian Federation
Yu. М. Gomon, А. С. Колбин
Clinical Microbiology and Antimicrobial Chemotherapy (2022), pp. 23-29
Open Access | Times Cited: 1
Does Health Economics Capture the Value of Mental Health?
James Lathe, Richard J. Silverwood, Alun D. Hughes, et al.
SSRN Electronic Journal (2023)
Closed Access
Abundance and prevalence of ESBL coding genes in patients undergoing first line eradication therapy for Helicobacter pylori
Dita Gudrā, Ivars Silamiķelis, Jānis Pjalkovskis, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289879-e0289879
Open Access
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study
Jason Gordon, Maria Gheorghe, Cale Harrison, et al.
PharmacoEconomics (2023) Vol. 42, Iss. 3, pp. 329-341
Open Access
Page 1 - Next Page

Scroll to top